Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination-Heplisav™ compared with Engerix-B(®) vaccine in adults.
| Autor: | De Ridder M; GlaxoSmithKline Vaccines, Belgium; Faculté de Pharmacie, Université Libre de Bruxelles, Belgium. Electronic address: marc.r.de-ridder@gsk.com., Curran D; GlaxoSmithKline Vaccines, Belgium., Leroux-Roels G; Center for Vaccinology, Ghent University and Hospital, Belgium. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Vaccine [Vaccine] 2015 Jun 22; Vol. 33 (28), pp. 3161. Date of Electronic Publication: 2014 Jun 02. |
| DOI: | 10.1016/j.vaccine.2014.05.033 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect